March 2020

Rheonix Inc. to Launch Rapid, Fully Automated Coronavirus Disease 2019 (COVID-19) Assay

Assay to provide small and medium-sized labs access to fast, cost-effective, sample-to-answer testing for public health threat ITHACA, N.Y. — Rheonix Inc., a leader in highly automated molecular diagnostics, today announced it is developing a coronavirus (COVID-19) test kit for use on its Encompass MDx® workstation. Upon Rheonix’s receipt of emergency use authorization (EUA) from the Food and Drug Administration (FDA), the new test will allow for the fully automated detection… Read More »
Rheonix receives FDA Emergency Use Authorization for Automated COVID-19 Test.
Learn More